# Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers

> **NCT00777361** · PHASE1 · TERMINATED · sponsor: **AstraZeneca** · enrollment: 9 (actual)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** AZD3480
- **DRUG:** AZD3480

## Key facts

- **NCT ID:** NCT00777361
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2010-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00777361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00777361, "Study of Uptake, Break Down and Elimination of an Investigational Drug in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00777361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*